Skye Bioscience's total assets for Q3 2025 were $41.32M, a decrease of -20.78% from the previous quarter. SKYE total liabilities were $8.49M for the fiscal quarter, a 0.05% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.